ABCB1 and central nervous system cancer: To clarify the mechanisms underlying celecoxib-mediated MDR1 down-regulation, we treated (i.p.)the mouse GSC-bearing glioma model with 10 mg/kg celecoxib for 7 days (Fig. 5a).